JP Patent

JP2005510449A — 改良型制御放出経口剤形

Assigned to アンドルックスファーマスーティカルズインコーポレーテッド · Expires 2005-04-21 · 21y expired

What this patent protects

１日１回用バプロピオン塩酸塩製剤を開示する。

USPTO Abstract

１日１回用バプロピオン塩酸塩製剤を開示する。

Drugs covered by this patent

Ativan (lorazepam) · Generic (originally Wyeth/Pfizer)

Patent Metadata

Patent number: JP2005510449A
Jurisdiction: JP
Classification: —
Expires: 2005-04-21
Drug substance claim: No
Drug product claim: No
Assignee: アンドルックスファーマスーティカルズインコーポレーテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.